These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8032178)

  • 1. Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications.
    Sharir M; Zimmerman TJ
    J Assoc Acad Minor Phys; 1994; 5(2):62-7. PubMed ID: 8032178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion.
    Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
    Am J Ophthalmol; 1992 Jul; 114(1):1-7. PubMed ID: 1621773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion.
    Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
    Am J Ophthalmol; 1992 Jul; 114(1):8-13. PubMed ID: 1621789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
    Sihota R; Agarwal HC; Rajashekar YL
    Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of silicone punctal plugs as adjuncts to topical pharmacotherapy of glaucoma--a pilot study. Punctal Plugs in Glaucoma Study Group.
    Bartlett JD; Boan K; Corliss D; Gaddie IB
    J Am Optom Assoc; 1996 Nov; 67(11):664-8. PubMed ID: 8979659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The additive effect of dipivefrin in patients with wide angle glaucoma treated with long-term beta-blocker therapy in comparison with clonidine].
    Alimgil ML; Erda S; Benian O
    Klin Monbl Augenheilkd; 1994 Aug; 205(2):114-6. PubMed ID: 7967405
    [No Abstract]   [Full Text] [Related]  

  • 7. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of primary open-angle glaucoma by oftan-dipivefrin].
    Egorov EA; Alekseev VN; Erichev VP; Usachev VV; Simonova SV; Iakubova LV
    Vestn Oftalmol; 2000; 116(1):32-3. PubMed ID: 10741262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined timolol and epinephrine therapy for open angle glaucoma.
    Knupp JA; Shields MB; Mandell AI; Hurvitz L; Spaeth GL
    Surv Ophthalmol; 1983 Dec; 28 Suppl():280-5. PubMed ID: 6665707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
    Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM
    Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma.
    Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO
    Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lowering the intraocular pressure by a combination of timolol with adrenergic agents].
    Pfeiffer N; Grehn F
    Fortschr Ophthalmol; 1988; 85(5):456-8. PubMed ID: 3224908
    [No Abstract]   [Full Text] [Related]  

  • 20. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.